Clinical Trial Update: Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MK-1029 in Participants With Mild to Moderate Asthma [Phase 1]

View source ↗

Summary

A Phase 1 study assessing the safety, tolerability, and pharmacokinetics of MK-1029 in adults with mild to moderate asthma; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• MK-1029

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Asthma | Phase 1 | Status: COMPLETED | Results posted: 2019-01-25